From Casetext: Smarter Legal Research

Errant Gene Therapeutics, LLC v. Sloan-Kettering Inst. for Cancer Research

Supreme Court, Appellate Division, First Department, New York.
Oct 8, 2019
176 A.D.3d 459 (N.Y. App. Div. 2019)

Opinion

10026N Index 150856/17

10-08-2019

ERRANT GENE THERAPEUTICS, LLC, Plaintiff–Respondent, v. SLOAN–KETTERING INSTITUTE FOR CANCER RESEARCH, et al., Defendants–Appellants.

Holland & Knight LLP, New York (Charles A. Weiss of counsel), and Wilmer Cutler Pickering Hale and Dorr LLP, New York (Robert J. Gunther, Jr. of counsel), for Sloan–Kettering Institute for Cancer Research, appellant. Schlam Stone & Dolan LLP, New York (John M. Lundlin of counsel), for Bluebird Bio Inc., appellant. McCue Sussmane Zapfel & Cohen, P.C., New York (Kenneth Sussmane of counsel), for respondent.


Holland & Knight LLP, New York (Charles A. Weiss of counsel), and Wilmer Cutler Pickering Hale and Dorr LLP, New York (Robert J. Gunther, Jr. of counsel), for Sloan–Kettering Institute for Cancer Research, appellant.

Schlam Stone & Dolan LLP, New York (John M. Lundlin of counsel), for Bluebird Bio Inc., appellant. McCue Sussmane Zapfel & Cohen, P.C., New York (Kenneth Sussmane of counsel), for respondent.

Friedman, J.P., Sweeny, Richter, Mazzarelli, Webber, JJ.

Order, Supreme Court, New York County (Barry R. Ostrager, J.), entered on or about June 6, 2019, which denied defendants' motion to strike plaintiff's jury demand, unanimously reversed, on the law, without costs, and the motion granted.

Plaintiff has waived its right to a jury trial. When, as here, the complaint either joins legal and equitable causes of action arising out of the same alleged wrong or seeks both legal and equitable relief, there is a waiver of a plaintiff's right to a jury trial (see Marko v. Korf, 166 A.D.3d 545, 89 N.Y.S.3d 44 [1st Dept. 2018] ; Security Pac. Natl. Bank v. Evans, 148 A.D.3d 465, 49 N.Y.S.3d 122 [1st Dept. 2017] ; Willis Re Inc. v. Hudson, 29 A.D.3d 489, 816 N.Y.S.2d 43 [1st Dept. 2006] ). Plaintiff's sixth cause of action for a permanent injunction sounds in equity, is not incidental to the remaining claims and as a result of its inclusion, it can no longer be said that money damages would afford a complete remedy (see e.g. Willis Re Inc., 29 A.D.3d at 489–490, 816 N.Y.S.2d 43 ). Furthermore, "[o]nce the right to a jury trial has been intentionally lost by joining legal and equitable claims, any subsequent dismissal, settlement or withdrawal of the equitable claim(s) will not revive the right to trial by jury" ( Zimmer–Masiello, Inc. v. Zimmer, Inc., 164 A.D.2d 845, 846–847, 559 N.Y.S.2d 888 [1st Dept. 1990] ).


Summaries of

Errant Gene Therapeutics, LLC v. Sloan-Kettering Inst. for Cancer Research

Supreme Court, Appellate Division, First Department, New York.
Oct 8, 2019
176 A.D.3d 459 (N.Y. App. Div. 2019)
Case details for

Errant Gene Therapeutics, LLC v. Sloan-Kettering Inst. for Cancer Research

Case Details

Full title:Errant Gene Therapeutics, LLC, Plaintiff-Respondent, v. Sloan-Kettering…

Court:Supreme Court, Appellate Division, First Department, New York.

Date published: Oct 8, 2019

Citations

176 A.D.3d 459 (N.Y. App. Div. 2019)
2019 N.Y. Slip Op. 7226
107 N.Y.S.3d 847

Citing Cases

Pelletier v. Morgan

We affirm. It is well settled that, when "the complaint either joins legal and equitable causes of action…

Schneider v. 254 Pas Prop.

Plaintiff has waived her right to a jury trial, as the complaint mingles legal and equitable claims arising…